Title:
NICLOSAMIDE DELAYED-RELEASE COMPOSITION AND ANTIVIRAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/040337
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for prevention or treatment of coronavirus infections, the pharmaceutical composition comprising a delayed-release composition of niclosamide or a pharmaceutically acceptable salt thereof. In addition, the present invention relates to a method for preventing or treating coronavirus infections by using the delayed-release composition.
Inventors:
LEE MINSUK (KR)
KANG BOKKI (KR)
PARK SANGHAN (KR)
KIM DONGHWAN (KR)
KANG BOKKI (KR)
PARK SANGHAN (KR)
KIM DONGHWAN (KR)
Application Number:
PCT/KR2020/011196
Publication Date:
March 04, 2021
Filing Date:
August 21, 2020
Export Citation:
Assignee:
DAEWOONG THERAPEUTICS INC (KR)
International Classes:
A61K9/00; A61K31/167; A61K47/02; A61K47/26; A61K47/38; A61P31/14
Foreign References:
| US7544712B1 | 2009-06-09 | |||
| CN108935457A | 2018-12-07 | |||
| CN101007170A | 2007-08-01 | |||
| CN101317564A | 2008-12-10 |
Other References:
WU CHANG-JER, JAN JIA-TSRONG, CHEN CHI-MIN, HSIEH HSING-PANG, HWANG DER-REN, LIU HWAN-WUN, LIU CHIU-YI, HUANG HUI-WEN, CHEN SU-CHI: "Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 48, no. 7, 1 July 2004 (2004-07-01), US, pages 2693 - 2696, XP055786816, ISSN: 0066-4804, DOI: 10.1128/AAC.48.7.2693-2696.2004
Attorney, Agent or Firm:
HANA IP LAW FIRM (KR)
Download PDF: